Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacia Is First Manufacturer Busted For Receiving Kickbacks From A PBM

Executive Summary

Pfizer subsidiary Pharmacia & Upjohn Company Inc. pleaded guilty to violating the Anti-Kickback Act, marking the first settlement by a manufacturer with prosecutors over excessive payments on a distribution contract with a pharmacy benefit manger

You may also be interested in...



Whistleblower Suits Alleging Off-label Promotion Need Not Be Specific – Gov’t

The U.S. government says whistleblowers do not need to provide specific details of misconduct in claiming a company marketed a drug for an unapproved use

Whistleblower Suits Alleging Off-label Promotion Need Not Be Specific – Gov’t

The U.S. government says whistleblowers do not need to provide specific details of misconduct in claiming a company marketed a drug for an unapproved use

Whistleblower suit against Pfizer reinstated

The U.S. Court of Appeals for the First Circuit rules Nov. 15 that Peter Rost, a former Pharmacia marketing exec, can amend his complaint against Pfizer alleging misconduct in the off-label marketing of the human growth hormone Genotropin. A lower court had granted Pfizer's motion to dismiss the suit on the grounds that it failed to specify details of the alleged fraud. The appeals court also rejects Pfizer's argument that its self-disclosure of potential misconduct barred a False Claims Act suit. "A 'public disclosure' requires that there be some act of disclosure to the public outside of the government," the court states. Pfizer, which acquired Pharmacia in 2003, pled guilty to violating the anti-kickback statute and paid the government $34.7 million to resolve federal investigations (1"The Pink Sheet" April 9, 2007, p. 3)...

Related Content

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel